03/24/2025
7:06 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/21/2025
4:24 PM | Tonix Pharmaceuticals (Filer)
| Form PRE 14A | |
03/18/2025
4:29 PM | Tonix Pharmaceuticals (Filer)
| Form ARS | |
03/18/2025
3:44 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2025
3:42 PM | Tonix Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/10/2025
7:06 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2025
4:28 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2025
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2025
4:30 PM | BAGGER RICHARD H (Reporting)
Tonix Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
4:31 PM | OLUKOTUN ADEOYE Y (Reporting)
Tonix Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
4:31 PM | Tonix Pharmaceuticals (Issuer)
Treco James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for TNXP and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Tonix Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
02/28/2025
4:32 PM | Bell Margaret Smith (Reporting)
Tonix Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
5:42 PM | Fogarty Siobhan (Reporting)
Tonix Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
5:44 PM | MORRIS JESSICA EDGAR (Reporting)
Tonix Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
5:48 PM | LEDERMAN SETH (Reporting)
Tonix Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
5:49 PM | SULLIVAN GREGORY M (Reporting)
Tonix Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2025
5:51 PM | SAENGER BRADLEY (Reporting)
Tonix Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
6:00 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/18/2025
5:00 AM | Fogarty Siobhan (Reporting)
Tonix Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/14/2025
4:05 PM | L1 Capital Global Opportunities Master Fund, Ltd. (Filed by)
Tonix Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/07/2025
7:52 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/06/2025
7:06 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/04/2025
6:09 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/03/2025
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2025
6:39 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2025
1:56 PM | SABBY MANAGEMENT, LLC (Filed by)
Tonix Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
12/23/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2024
3:16 PM | Tonix Pharmaceuticals (Filer)
| Form 424B5 | |
12/20/2024
3:17 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/17/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2024
3:13 PM | Tonix Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
12/03/2024
4:15 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K/A | |
12/03/2024
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
8:10 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
4:10 PM | Tonix Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/04/2024
6:30 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2024
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2024
3:30 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/28/2024
4:16 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/16/2024
8:01 AM | Empery Asset Management, LP (Filed by)
Tonix Pharmaceuticals (Subject)
| Form SC 13G/A | |
New “Trump” currency proposed in DC (Ad) According to one of the most connected men in Washington…
A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note.
All to celebrate a new “golden age” for America.
 When you see what could happen – I think you’ll be excited. |
10/16/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/08/2024
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/30/2024
11:15 PM | Tonix Pharmaceuticals (Filer)
| Form EFFECT | |
09/27/2024
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/23/2024
4:09 PM | Tonix Pharmaceuticals (Filer)
| Form DEF 14A | |
09/23/2024
6:08 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/20/2024
4:03 PM | Tonix Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
09/19/2024
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/16/2024
6:23 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/13/2024
4:00 PM | Tonix Pharmaceuticals (Filer)
| Form PRE 14A | |
09/10/2024
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2024
6:07 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/06/2024
4:17 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/30/2024
4:04 PM | Tonix Pharmaceuticals (Filer)
| Form 424B5 | |
08/30/2024
4:08 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/29/2024
6:02 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/26/2024
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/20/2024
6:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/19/2024
5:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/16/2024
4:18 PM | Tonix Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/15/2024
5:03 AM | Tonix Pharmaceuticals (Filer)
| Form NT 10-Q | |
08/12/2024
7:18 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
4:22 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2024
4:08 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2024
4:17 PM | Tonix Pharmaceuticals (Filer)
| Form 424B5 | |
07/25/2024
7:06 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/24/2024
4:14 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K/A | |
07/16/2024
8:12 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2024
3:48 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/09/2024
3:33 PM | Tonix Pharmaceuticals (Filer)
| Form 424B5 | |
07/08/2024
4:01 PM | Tonix Pharmaceuticals (Filer)
| Form 424B5 | |
07/08/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/01/2024
5:45 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/28/2024
4:25 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2024
4:09 PM | Tonix Pharmaceuticals (Filer)
| Form 424B5 | |
06/26/2024
3:52 PM | Tonix Pharmaceuticals (Filer)
| Form 424B5 | |
06/26/2024
3:14 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2024
4:25 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K/A | |
06/13/2024
4:24 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2024
3:49 PM | Tonix Pharmaceuticals (Filer)
| Form 424B5 | |
06/10/2024
7:53 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2024
10:21 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/30/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2024
4:10 PM | Taylor Carolyn E. (Reporting)
Tonix Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2024
4:10 PM | Tonix Pharmaceuticals (Issuer)
Treco James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
7:05 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/21/2024
7:07 AM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
New “Trump” currency proposed in DC (Ad) According to one of the most connected men in Washington…
A surprising new bill was just introduced in Washington. Its purpose: to put Donald Trump’s face on the $100 note.
All to celebrate a new “golden age” for America.
When you see what could happen – I think you’ll be excited. |
05/13/2024
3:56 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/15/2024
3:49 PM | Tonix Pharmaceuticals (Filer)
| Form ARS | |
04/15/2024
3:38 PM | Tonix Pharmaceuticals (Filer)
| Form DEF 14A | |
04/05/2024
3:47 PM | Tonix Pharmaceuticals (Filer)
| Form PRE 14A | |
03/29/2024
4:28 PM | Tonix Pharmaceuticals (Filer)
| Form 424B5 | |
03/29/2024
4:16 PM | Tonix Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
